How Do You Advertise TRT on Meta and Google Without Losing the Account?

What this means for you

• Two layers: clinic and program ads run now; prescription-product ads run only after certification on both platforms.
• "Low T?" and "not what you used to be?" are personal-attribute violations on Meta. "Testosterone therapy is available" is not.
• Testosterone is a Schedule III controlled substance. Its promotion is flagged separately on every platform and lands on the account, not the ad.
• Enclomiphene, hCG and peptides are not FDA-approved drugs and cannot be advertised as products. They belong on the page after the click, framed as clinical options.
• A landing page that lists medications with prices and a cart reads as a pharmacy to a reviewer and re-tiers the whole account.

MedScale Health, a patient-acquisition agency for telehealth and clinics, runs TRT campaigns for telehealth brands whose product is a monthly subscription with labs, a prescriber visit and a partner pharmacy. The rules below are the ones that decide whether such a brand keeps its ad accounts. This page is marketing guidance for healthcare operators. It is not medical or legal advice, and platform policies change: check the sources listed at the end before acting on any specific rule.

Meta: the three standards a TRT ad collides with

Meta's drugs and pharmaceuticals standard requires active LegitScript certification and Meta's written authorization before an advertiser may promote prescription drugs, limits that advertising to adults and to a short list of countries including the United States, and requires a consult-a-professional disclaimer. Ads promoting telehealth services generally are exempt, which is the opening for the clinic layer.

The personal attributes standard prohibits copy that asserts or implies a viewer's medical condition or health status. It is the most common men's health rejection, because the category's natural hooks are all second-person symptom questions. The fix is grammatical: the subject of the sentence is the program, not the reader. Sexualised imagery and shirtless creative fail under the health and wellness and adult-content standards on top of that.

The third collision is structural rather than creative. Meta categorises data sources associated with medical conditions and provider relationships and restricts what they may send. A site that names and prices testosterone cypionate for sale is an online pharmacy in that reading whether or not the operator thinks of itself as one, and the restriction applies to the pixel and the account, not to one ad.

Google: certification first, then drug terms

Google requires advertisers to be certified in order to serve ads for prescription drug services, which covers telemedicine that facilitates prescribing. In the United States that certification is backed by LegitScript. Without it, restricted drug terms (testosterone, the ED medications, finasteride) in keywords or ad text are rejected automatically, and using misspellings to get around the filter is treated as circumvention, which is the label that ends accounts.

What is open without certification is intent that does not name a drug: "TRT online", "testosterone clinic near me", "men's health telehealth". Those campaigns are where a new brand starts, and drug-term campaigns are added when the certification lands.

The controlled-substance layer

Testosterone is Schedule III. Two consequences follow for marketing. First, the telemedicine rules for prescribing controlled substances without an in-person visit rest on temporary federal flexibilities that have been extended repeatedly, most recently by the fourth temporary extension published in the Federal Register at the end of 2025, and state rules layer on top. A TRT brand's visit model, prescriber licensing and pharmacy choice all depend on those rules, and an ad that promises something the model cannot lawfully deliver in a state is a problem larger than a rejected ad.

Second, LegitScript examines prescribing and dispensing practices for controlled substances during certification, and the platforms flag controlled-substance promotion as a distinct category. Creative that stays on the program and the labs gives that flag no reason to fire.

Enclomiphene, hCG and peptides

The fertility-preserving alternatives most TRT brands offer are usually compounded, not FDA-approved, and enclomiphene is not an FDA-approved drug at all. On Google they fall under unapproved pharmaceuticals and cannot be advertised. On Meta they fall under the unapproved-substances reading of the drugs standard. The ad names the program and the provider; enclomiphene is explained on the page after the click, framed as a clinical option the prescriber may consider, with the compounded status stated plainly. Peptides presented as products are the single most common cause of a men's health account being disabled for unsafe substances.

Creative and landing pages that pass

• Ads show the labs, the visit, the follow-up and the price. Providers speak to camera. No bodies, no transformation imagery, no "you".
• Drug names stay on the page, never in ad text or keyword lists, until certification is active.
• The landing page leads with the program and the lab panel, puts medication options second, and states the controlled-substance and telemedicine requirements in plain language.
• Once certified, the certification seal appears in the footer of every page an ad can land on, and consultation campaigns and authorized-product campaigns never share an ad set, because a campaign is judged by its most regulated product.
• Tracking events are named generically. A pixel event called after testosterone re-tiers the account on its first fire.

TikTok

Prescription medicine is not an allowed ad subject in the United States on TikTok, and sexual-health and men's-health content is reviewed as restricted. TikTok works for provider-led education that sends men to organic search; it does not work for a direct-response TRT offer, and an operator should not build a channel plan that assumes it will.

How the two layers run side by side

The clinic layer is not a placeholder while certification is pending; it is the durable core of a TRT account. Search campaigns on treatment intent, Meta campaigns on the lab-first offer and the prescriber, and provider-led video that sends men to organic search all keep running after certification arrives. What certification adds is a second set of campaigns, in their own ad sets, that may name the prescription products and bid on drug terms. Keeping the two layers separate is not tidiness: a campaign is judged by its most regulated product, so a single authorized-product ad in a consultation ad set drags the whole set under the prescription rules.

The same separation applies to the pages. The page a clinic-layer ad lands on leads with the lab panel, the visit and the follow-up cadence; the page an authorized-product ad lands on may name the products, with the certification seal in the footer and the compounded status of any compounded product stated plainly. A landing page that does both jobs at once tends to fail both reviews.

What to measure

The metric that decides a TRT campaign is not cost per lead but cost per qualified lead, defined as a lab ordered or an intake completed with a state the brand can serve, and then the consult booked, the prescription issued and the patient still shipping at month three. Those events happen in the intake platform and the pharmacy system, not on the website, so the ad click has to travel with the patient into those systems and the events have to come back server-side with generic names. A brand that reports form fills to Meta and Google is optimising toward the men who abandon at the lab step, which is the most expensive place in the funnel to be wrong.

What MedScale does

MedScale Health runs TRT telehealth acquisition as described on medscale.health/telehealth/trt-mens-health: a policy read of every ad, page and pixel event with the controlled-substance flags listed separately, server-side tracking that carries the ad click through labs, the visit and the prescription, lab-first campaigns on Google and Meta, and weekly reporting of cost per qualified lead through prescriptions issued by state and campaign. Where the brand wants to name products, the LegitScript filing runs alongside the clinic-layer campaigns rather than ahead of them.